Details
June 7 @ 12:30 pm – 1:30 pm CDT
Product Theater 2
Supported By: Corcept Therapeutics
Program Description
Attendees will hear a patient share their personal journey from diagnosis to treatment with Korlym®, alongside expert clinician perspectives on relevant and emerging data. Please see the full Prescribing Information including BOXED WARNING for Termination of Pregnancy, at the Product Theater and at korlym.com/hcp.
This program is not part of the 2026 Scientific Sessions as planned by the American Diabetes Association® (ADA). This event is neither sponsored nor endorsed by the ADA. This event does not qualify for continuing medical education (CME) credit.
Corcept leads the field in the research and development of selective glucocorticoid receptor (GR) antagonists, having discovered more than 500 proprietary molecules since being founded in 1998. Corcept is committed to improving patient lives through the discovery and development of drugs that address serious unmet medical needs related to excess cortisol activity.
Speakers
Panelist
Bradley Eilerman MD, MHI
Adjunct Assistant Professor
Professor of Medicine University of Kentucky College of Medicine
Eilerman Endocrinology, LLC
Covington, KY
Panelist
Ralph DeFronzo MD
Professor of Medicine
Chief, Diabetes Division
University of Texas Health
San Antonio, TX
Resources
Please see the Important Safety Information, including Boxed Warning